Reports a case where an EGFR-mutated squamous cell lung carcinoma transformed into small cell lung carcinoma during osimertinib therapy, with retained EGFR mutation.
Key Takeaways
- You have multiple emails registered with Frontiers: You don't have a Frontiers account ?
- We report the case of a 42-year-old male initially diagnosed with stage IIIA EGFR-mutated SCC
- Upon clinical progression during osimertinib therapy, a repeat biopsy was performed